Skip to main content
logo
Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
20.13
+0.71 (3.68%)
Sep 3, 2026, 1:51 PM EDT - Market open

Beta Bionics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
9061,341---
Market Cap Growth
10.58%----
Enterprise Value
7321,120---
Last Close Price
19.4130.47---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
7.5813.38---
PB Ratio
3.414.66---
P/TBV Ratio
3.524.66---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.1211.18---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.030.030.100.070.32
Net Debt / Equity Ratio
-0.68-0.74-1.27-1.58-1.81
Net Debt / EBITDA Ratio
2.153.022.182.670.37
Net Debt / FCF Ratio
2.833.771.862.820.39
Asset Turnover
0.380.420.500.17-
Inventory Turnover
2.412.554.01--
Quick Ratio
7.727.735.529.543.12
Current Ratio
8.888.666.299.773.21
Return on Equity (ROE)
-26.16%-40.26%-81.35%-123.17%-
Return on Assets (ROA)
-16.67%-18.73%-21.78%-30.79%-
Return on Capital Employed (ROCE)
-31.20%-24.10%-35.20%-36.10%-242.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-8.09%-5.46%---
FCF Yield
-6.80%-4.19%---
Buyback Yield / Dilution
-102.32%-536.74%-20.01%-6.13%-
SEC Filings: 10-K · 10-Q